Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Jul:43:25-32.
doi: 10.1016/j.cct.2015.04.014. Epub 2015 May 4.

A centralized cardiovascular risk service to improve guideline adherence in private primary care offices

Barry L Carter  1 , Barcey T Levy  2 , Brian Gryzlak  3 , Elizabeth A Chrischilles  4 , Mark W Vander Weg  5 , Alan J Christensen  6 , Paul A James  2 , Carol A Moss  2 , Christopher P Parker  7 , Tyler Gums  7 , Rachel J Finkelstein  7 , Yinghui Xu  2 , Jeffrey D Dawson  8 , Linnea A Polgreen  7
Affiliations
Randomized Controlled Trial

A centralized cardiovascular risk service to improve guideline adherence in private primary care offices

Barry L Carter et al. Contemp Clin Trials. 2015 Jul.

Abstract

Background: Many large health systems now employ clinical pharmacists in team-based care to assist patients and physicians with management of cardiovascular (CV) diseases. However, small private offices often lack the resources to hire a clinical pharmacist for their office. The purpose of this study is to evaluate whether a centralized, web-based CV risk service (CVRS) managed by clinical pharmacists will improve guideline adherence in primary care medical offices in rural and small communities.

Methods: This study is a cluster randomized prospective trial in 12 primary care offices. Medical offices were randomized to either the CVRS intervention or usual care. The intervention will last for 12 months and all subjects will have research visits at baseline and 12 months. Primary outcomes will include adherence to treatment guidelines and control of key CV risk factors. Data will also be abstracted from the medical record at 30 months to determine if the intervention effect is sustained after it is discontinued.

Conclusions: This study will enroll subjects through 2015 and results will be available in 2018. This study will provide information on whether a distant, centralized CV risk service can improve guideline adherence in medical offices that lack the resources to employ clinical pharmacists.

Keywords: Cardiovascular disease; Clinical trial; Diabetes; Guideline adherence; Pharmacist management.

PubMed Disclaimer

References

    1. Milchak JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension. 2004;44:602–608. - PMC - PubMed
    1. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–1465. - PubMed
    1. Rodondi N, Peng T, Karter AJ, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144:475–484. - PMC - PubMed
    1. Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140:714–720. - PubMed
    1. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension. 2008;51:1149–1155. - PubMed

Publication types

MeSH terms